218 related articles for article (PubMed ID: 37171586)
1. Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
Oda S; Kuno H; Hiyama T; Sakashita S; Sasaki T; Kobayashi T
Abdom Radiol (NY); 2023 Aug; 48(8):2503-2513. PubMed ID: 37171586
[TBL] [Abstract][Full Text] [Related]
2. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
[TBL] [Abstract][Full Text] [Related]
3. Multidetector CT for Restaging Locally Advanced Esophageal Squamous Cell Carcinoma and Assessing Therapeutic Response to Neoadjuvant Chemotherapy.
Shi Y; Chen Y; Li X; Wang Z; Sun Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):133-139. PubMed ID: 28270296
[TBL] [Abstract][Full Text] [Related]
4. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
[TBL] [Abstract][Full Text] [Related]
5. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
6. Using clinical and radiomic feature-based machine learning models to predict pathological complete response in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation.
Wang J; Zhu X; Zeng J; Liu C; Shen W; Sun X; Lin Q; Fang J; Chen Q; Ji Y
Eur Radiol; 2023 Dec; 33(12):8554-8563. PubMed ID: 37439939
[TBL] [Abstract][Full Text] [Related]
7. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
[TBL] [Abstract][Full Text] [Related]
8.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
9. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
[TBL] [Abstract][Full Text] [Related]
10. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
[TBL] [Abstract][Full Text] [Related]
11. CT radiomics identifying non-responders to neoadjuvant chemoradiotherapy among patients with locally advanced rectal cancer.
Zhang Z; Yi X; Pei Q; Fu Y; Li B; Liu H; Han Z; Chen C; Pang P; Lin H; Gong G; Yin H; Zai H; Chen BT
Cancer Med; 2023 Feb; 12(3):2463-2473. PubMed ID: 35912919
[TBL] [Abstract][Full Text] [Related]
12. CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: A dual-center study.
Song R; Cui Y; Ren J; Zhang J; Yang Z; Li D; Li Z; Yang X
Radiother Oncol; 2022 Jun; 171():155-163. PubMed ID: 35490846
[TBL] [Abstract][Full Text] [Related]
13. Prediction of distant metastasis in esophageal cancer using a radiomics-clinical model.
Zhu C; Mu F; Wang S; Qiu Q; Wang S; Wang L
Eur J Med Res; 2022 Dec; 27(1):272. PubMed ID: 36463269
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prediction of vessel invasion in locally advanced gastric cancer based on computed tomography radiomics and machine learning.
Hu ZW; Liang P; Li ZL; Yong LL; Lu H; Wang R; Gao JB
Oncol Lett; 2023 Jul; 26(1):293. PubMed ID: 37274479
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
[TBL] [Abstract][Full Text] [Related]
16. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
17. The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Song T; Yao Q; Qu J; Zhang H; Zhao Y; Qin J; Feng W; Zhang S; Han X; Wang S; Yan X; Li H
Eur Radiol; 2021 Mar; 31(3):1391-1400. PubMed ID: 32901300
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI-based radiomics nomogram for early prediction of pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yin H; Wang Y; Zhang H; Ma F; Li H; Qu J
Eur Radiol; 2023 Apr; 33(4):2746-2756. PubMed ID: 36512039
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics.
Jin X; Zheng X; Chen D; Jin J; Zhu G; Deng X; Han C; Gong C; Zhou Y; Liu C; Xie C
Eur Radiol; 2019 Nov; 29(11):6080-6088. PubMed ID: 31028447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
